Hizentra® CIDP

Have a Question? Use Our New Chat Feature! Chat with our Medical Information Specialists by clicking on the Chat with us now available in the lower right corner of this screen.

Product Information	Educational Materials	Conferences and Events	Key Publications

Posters

Subcutaneous Immunoglobulin (IgPro20) Dose Adjustments for Chronic Inflammatory Demyelinating Polyneuropathy Maintenance Therapy in Clinical Practice

View Poster

Please see full prescribing information for HIZENTRA

Real-world experience of needle length use based on BMI for IgPro20 administration

View Poster

Please see full prescribing information for HIZENTRA

Key Publications

Subcutaneous Immunoglobulin for maintenance treatment in CIDP (PATH): a randomized, double-blind, placebo-controlled, phase 3 trial

van Schaik, IN et al
Lancet Neurol, 2017
Request | Ask a Question | View Article

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (The PATH study): study protocol for a randomized controlled trial.

van Schaik, IN et al
Trials, 2016
Request | Ask a Question | View Article

Long-term safety and efficacy of subcutaneous immunoglobulin IgPro20 in CIDP

Van Schaik, IN et al
Neurol NeuroimmunolNeuroinflamm, 2019
Request | Ask a Question | View Article